HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Alpha-methylprednisolone conjugated cyclodextrin polymer-based nanoparticles for rheumatoid arthritis therapy.

Abstract
A glycinate derivative of alpha-methylprednisolone (MP) was prepared and conjugated to a linear cyclodextrin polymer (CDP) with a loading of 12.4% w/w. The polymer conjugate (CDP-MP) self-assembled into nanoparticles with a size of 27 nm. Release kinetics of MP from the polymer conjugate showed a half-life (t1/2) of 50 h in phosphate buffer solution (PBS) and 19 h in human plasma. In vitro, the proliferation of human lymphocytes was suppressed to a similar extent but with a delayed effect when CDP-MP was compared with free MP. In vivo, CDP-MP was administered intravenously to mice with collagen-induced arthritis and compared with free MP. CDP-MP was administered weekly for six weeks (0.07, 0.7, and 7 mg/kg/week) and MP was administered daily for six weeks (0.01, 0.1, and 1 mg/kg/day). Body weight changes were minimal in all animals. After 28 days, a significant decrease in arthritis score was observed in animals treated weekly with an intermediate or high dose of CDP-MP. Additionally, dorsoplantar swelling was reduced to baseline in animals treated with CDP-MP at the intermediate and high dose level. Histological evaluation showed a reduction in synovitis, pannus formation and disruption of architecture at the highest dose level of CDP-MP. MP administered daily at equivalent cumulative doses showed minimal efficacy in this model. This study demonstrates that conjugation of MP to a cyclodextrin-polymer may improve its efficacy, leading to lower doses and less frequent administration for a safer and more convenient management of rheumatoid arthritis.
AuthorsJungyeon Hwang, Kathleen Rodgers, James C Oliver, Thomas Schluep
JournalInternational journal of nanomedicine (Int J Nanomedicine) Vol. 3 Issue 3 Pg. 359-71 ( 2008) ISSN: 1176-9114 [Print] New Zealand
PMID18990945 (Publication Type: Journal Article)
Chemical References
  • Cyclodextrins
  • Drug Carriers
  • Polymers
  • Methylprednisolone
Topics
  • Animals
  • Arthritis, Rheumatoid (drug therapy, pathology)
  • Cell Proliferation (drug effects)
  • Cells, Cultured
  • Cyclodextrins (administration & dosage, chemistry)
  • Drug Carriers (chemistry)
  • Humans
  • Lymphocytes (cytology, drug effects)
  • Methylprednisolone (administration & dosage, chemistry)
  • Mice
  • Nanoparticles (chemistry, ultrastructure)
  • Polymers (chemistry)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: